Laurie Menger

6.3k total citations · 1 hit paper
23 papers, 3.0k citations indexed

About

Laurie Menger is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Laurie Menger has authored 23 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 11 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in Laurie Menger's work include CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (5 papers) and Adenosine and Purinergic Signaling (5 papers). Laurie Menger is often cited by papers focused on CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (5 papers) and Adenosine and Purinergic Signaling (5 papers). Laurie Menger collaborates with scholars based in France, United Kingdom and United States. Laurie Menger's co-authors include Oliver Kepp, Guido Kroemer, Laurence Zitvogel, Isabelle Martins, Sandy Adjemian, Lorenzo Galluzzi, Mickaël Michaud, Abdul Qader Sukkurwala, Erika Vacchelli and Shensi Shen and has published in prestigious journals such as Science, The Journal of Experimental Medicine and Blood.

In The Last Decade

Laurie Menger

22 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice

2011 1.1k citations Mickaël Michaud, Isabelle Martins et al. profile →

Peers

Countries citing papers authored by Laurie Menger

Since Specialization

Citations

This map shows the geographic impact of Laurie Menger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurie Menger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurie Menger more than expected).

Fields of papers citing papers by Laurie Menger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurie Menger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurie Menger. The network helps show where Laurie Menger may publish in the future.

Co-authorship network of co-authors of Laurie Menger

This figure shows the co-authorship network connecting the top 25 collaborators of Laurie Menger. A scholar is included among the top collaborators of Laurie Menger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurie Menger. Laurie Menger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CAR T cell–mediated bone marrow inflammation causes hematotoxicity and favors clonal hematopoiesis 2025 ·Science Translational Medicine ·(unknown), (unknown), (unknown), (unknown), Véronique Vergé, Arnaud Pagès, (unknown), (unknown), (unknown), (unknown), Vincent Ribrag, (unknown), (unknown), Stéphane de Botton, Laurie Menger, Iléana Antony‐Debré, (unknown), Christophe Marzac, Cristina Castilla Llorente, Camille Bigenwald	0
2	Ablation of FAS confers allogeneic CD3– CAR T cells with resistance to rejection by T cells and natural killer cells 2024 ·Nature Biomedical Engineering ·Silvia Menegatti, Sheila López‐Cobo, (unknown), (unknown), (unknown), (unknown), Sandrine Heurtebise-Chrétien, (unknown), Aurélie Darbois, Nina Burgdorf, (unknown), Albane Simon, (unknown), Michael Saitakis, (unknown), Beau R. Webber, Branden S. Moriarity, Olivier Lantz, Sebastián Amigorena, Laurie Menger	7
3	Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-γ is a major determinant of CD4+ CAR T-cell antitumor activity 2023 ·Nature Cancer ·Morgane Boulch, Marine Cazaux, Alexis Cuffel, Marion V. Guérin, Zacarias Garcia, Ruby Alonso, Fabrice Lemaı̂tre, (unknown), Béatrice Corre, Laurie Menger, Capucine L. Grandjean, Florence Morin, Catherine Thiéblemont, Sophie Caillat‐Zucman, Philippe Bousso	67
4	Optimized protocol to generate genome-wide inactivated Cas9-expressing murine T cells 2022 ·STAR Protocols ·(unknown), (unknown), Laurie Menger	1
5	In vivo genome-wide CRISPR screens identify SOCS1 as intrinsic checkpoint of CD4 ⁺ T _H 1 cell response 2021 ·Science Immunology ·(unknown), Silvia Menegatti, (unknown), Francesca Lucibello, (unknown), Julie Helft, Aurélie Darbois, Michael Saitakis, Jimena Tosello, Derek C. Rookhuizen, Marc Deloger, Pierre Gestraud, Gèrard Socié, Sebastián Amigorena, Olivier Lantz, Laurie Menger	41
6	Methods to edit T cells for cancer immunotherapy 2019 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Francesca Lucibello, Silvia Menegatti, Laurie Menger	2
7	A common transcriptomic program acquired in the thymus defines tissue residency of MAIT and NKT subsets 2018 ·The Journal of Experimental Medicine ·Marion Salou, François Legoux, Jules Gilet, Aurélie Darbois, (unknown), Ruby Alonso, (unknown), Anne‐Gaëlle Goubet, (unknown), Laurie Menger, Emanuele Procopio, Virginie Prémel, Olivier Lantz	135
8	TALEN-Mediated Inactivation of PD-1 in Tumor-Reactive Lymphocytes Promotes Intratumoral T-cell Persistence and Rejection of Established Tumors 2016 ·Cancer Research ·Laurie Menger, Anna Śledzińska, Katharina Bergerhoff, Frederick Arce Vargas, Julianne Smith, Laurent Poirot, Martin Pulé, Javier Herrero, Karl S. Peggs, Sergio A. Quezada	62
9	Negative immune checkpoints on T lymphocytes and their relevance to cancer immunotherapy 2015 ·Molecular Oncology ·Anna Śledzińska, Laurie Menger, Katharina Bergerhoff, Karl S. Peggs, Sergio A. Quezada	61
10	Trial watch 2013 ·OncoImmunology ·Laurie Menger, Erika Vacchelli, Oliver Kepp, Alexander Eggermont, Éric Tartour, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi	108
11	Fluorescent Biosensors for the Detection of HMGB1 Release 2013 ·Methods in molecular biology ·Isabelle Martins, Oliver Kepp, Laurie Menger, Mickaël Michaud, Sandy Adjemian, Abdul Qader Sukkurwala, Erika Vacchelli, Lorenzo Galluzzi, Guido Kroemer	10
12	Crosstalk between ER stress and immunogenic cell death 2013 ·Cytokine & Growth Factor Reviews ·Oliver Kepp, Laurie Menger, Erika Vacchelli, Clara Locher, Sandy Adjemian, Takahiro Yamazaki, Isabelle Martins, Abdul Qader Sukkurwala, Michael Michaud, Laura Senovilla, Lorenzo Galluzzi, Guido Kroemer, Laurence Zitvogel	191
13	Quantification of Cell Cycle-Arresting Proteins 2012 ·Methods in molecular biology ·Oliver Kepp, Isabelle Martins, Laurie Menger, Mickaël Michaud, Sandy Adjemian, Abdul Qader Sukkurwala, Lorenzo Galluzzi, Guido Kroemer	1
14	Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death 2012 ·Autophagy ·Isabelle Martins, Mickaël Michaud, Abdul Qader Sukkurwala, Sandy Adjemian, Yuting Ma, Shensi Shen, Oliver Kepp, Laurie Menger, Erika Vacchelli, Lorenzo Galluzzi, Laurence Zitvogel, Guido Kroemer	90
15	Anticancer activity of cardiac glycosides 2012 ·OncoImmunology ·Oliver Kepp, Laurie Menger, Erika Vacchelli, Sandy Adjemian, Isabelle Martins, Yuting Ma, Abdul Qader Sukkurwala, Mickaël Michaud, Lorenzo Galluzzi, Laurence Zitvogel, Guido Kroemer	83
16	Loss-of-function alleles ofP2RX7andTLR4fail to affect the response to chemotherapy in non-small cell lung cancer 2012 ·OncoImmunology ·Erika Vacchelli, Lorenzo Galluzzi, Vanessa Rousseau, Alice Rigoni, Antoine Tesnière, Nicolas Delahaye, F. Schlemmer, Laurie Menger, Abdul Qader Sukkurwala, Sandy Adjemian, Isabelle Martins, Mickaël Michaud, Ariane Dunant, Oliver Kepp, Élisabeth Brambilla, Jean‐Charles Soria, Laurence Zitvogel, Guido Kroemer	33
17	Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy 2011 ·Cancer and Metastasis Reviews ·Oliver Kepp, Lorenzo Galluzzi, Isabelle Martins, F. Schlemmer, Sandy Adjemian, Mickaël Michaud, Abdul Qader Sukkurwala, Laurie Menger, Laurence Zitvogel, Guido Kroemer	224
18	Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress 2010 ·Oncogene ·Isabelle Martins, Oliver Kepp, F. Schlemmer, Sandy Adjemian, Maximilien Tailler, Shensi Shen, Mickaël Michaud, Laurie Menger, Abdelaziz Gdoura, Nicolas Tajeddine, Antoine Tesnière, Laurence Zitvogel, Guido Kroemer	329
19	Immunogenic Tumor Cell Death for Optimal Anticancer Therapy: The Calreticulin Exposure Pathway 2010 ·Clinical Cancer Research ·Laurence Zitvogel, Oliver Kepp, Laura Senovilla, Laurie Menger, Nathalie Chaput, Guido Kroemer	313
20	Surface‐exposed calreticulin in the interaction between dying cells and phagocytes 2010 ·Annals of the New York Academy of Sciences ·Isabelle Martins, Oliver Kepp, Lorenzo Galluzzi, Laura Senovilla, F. Schlemmer, Sandy Adjemian, Laurie Menger, Mickaël Michaud, Laurence Zitvogel, Guido Kroemer	90

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact